Rheumatoid arthritis: Difference between revisions

No edit summary
No edit summary
Line 18: Line 18:


==Evaluation==
==Evaluation==
*Xray affected joints
*Xray affected joints for erosions
*Rheumatoid factor
*Rheumatoid factor (positive in 60% to 70% of patients)
*Anti-cyclic citrullinated peptide (CCP) antibodies
*Anti-cyclic citrullinated peptide (CCP) antibodies (positive in about 70% of patients)
*ANA
*ANA
*Consider [[arthrocentesis]]
*Consider [[arthrocentesis]]

Revision as of 20:04, 28 July 2016

Background

  • Erosive polyarthritis

Clinical Features

  • Morning stiffness
  • Polyarthritis of MCP and PIP joints
    • Does NOT involve DIP joints
    • Wrists, elbows, shoulders, ankles, knees also commonly involved
  • Ulnar deviation at the wrist
  • Rheumatoid nodules
  • Most patients initially diagnosed in the early 50s
  • Common associated conditions in severe cases: pleuritis, interstital lung disease, pericarditis, inflammatory eye disease

Differential Diagnosis

Polyarthritis

Algorithm for Polyarticular arthralgia

Evaluation

  • Xray affected joints for erosions
  • Rheumatoid factor (positive in 60% to 70% of patients)
  • Anti-cyclic citrullinated peptide (CCP) antibodies (positive in about 70% of patients)
  • ANA
  • Consider arthrocentesis
    • WBC count typically 1,500-20,000

Management

  • NSAIDs
    • Symptomatic relief without slowing underlying disease
  • Glucocorticoids
    • Consider intraarticular injection if a single joint is inflammed
    • Systemic steroids reserved for moderate-severe flairs
  • Opiods have a limited role
  • Disease-modifying antirheumatic drug (DMARD)
    • Can be started by primary care provider or rheumatologist after ER visit

Disposition

  • Refer to primary care provider or rheumatologist

See Also

References